Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Burden of Hospitalized Pneumonia in Korea COPD Population
- Status
- UNKNOWN
- Phase
- N/A
A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)
- Status
- COMPLETED
- Phase
- PHASE3
Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Sayana Press UK Self-Injection Study
- Status
- COMPLETED
- Phase
- PHASE4
Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
- Status
- COMPLETED
- Phase
- N/A
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Ascending Dose and DDI Study
- Status
- COMPLETED
- Phase
- PHASE1
Improving Value of Care for Patients With Severe Stasis Dermatitis
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease
- Status
- WITHDRAWN
- Phase
- PHASE4
Safety and Tolerability of PF-06818883 in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-
- Status
- COMPLETED
- Phase
- N/A
Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis
- Status
- COMPLETED
- Phase
- PHASE1
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
- Status
- COMPLETED
- Phase
- NA